TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor 1
about
The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasisIL12Rβ1ΔTM is a secreted product of il12rb1 that promotes control of extrapulmonary tuberculosisPlacental expression of miR-517a/b and miR-517c contributes to trophoblast dysfunction and preeclampsiaIncreased CSF biomarkers of angiogenesis in Parkinson diseaseTNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by DiabetesA case-control study about the association between vascular endothelial growth inhibitor gene polymorphisms and breast cancer risk in female patients in Northeast China.TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals.Jmjd6, a JmjC Dioxygenase with Many Interaction Partners and Pleiotropic FunctionsChanges in TL1A levels and associated cytokines during pathogenesis of diabetic retinopathy.The oxygenase Jmjd6--a case study in conflicting assignments.Vascular precursor cells in tissue injury repair.Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.Vascular endothelial growth factor suppresses TNFSF15 production in endothelial cells by stimulating miR-31 and miR-20a expression via activation of Akt and Erk signals.Jumonji domain containing protein 6 (Jmjd6) modulates splicing and specifically interacts with arginine-serine-rich (RS) domains of SR- and SR-like proteins.Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.Bone Marrow-Derived Endothelial Progenitor Cells Reduce Recurrent Miscarriage in Gestation.Increased cardiac remodeling in cardiac-specific Flt-1 receptor knockout mice with pressure overload.Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
P2860
Q29544441-DA8652C2-CA17-4162-873A-01A17893EF41Q34955491-3D34F046-88EC-4B37-B2FF-2744D500D2ECQ35208938-F2589AA2-9179-4B2F-A575-1C9E0095D658Q35825166-90546E38-4FF3-472F-B066-AD9C636FFEFCQ36939054-9CB684A5-DD9F-468F-94F2-661C8435E21BQ37246949-94E813DA-7130-4DA3-8C9C-238705CEECF9Q37688387-D12CE83E-115D-4D72-88D4-7744814C3306Q37703058-9E533D47-A348-4C7C-90C2-C35CB28362E6Q37720009-D7884646-6CE9-4A06-A7DA-6492A324A961Q38495832-BA567975-6869-4AE4-9875-E4338FA38DCFQ39174289-85F65921-16BA-4497-88DD-0246004BEA10Q40814371-54033888-DA5F-47EA-A6D1-5BFE15DE0F2BQ41017078-7FFDDB81-E8C9-4A4C-95D8-5DDB17CF0C9FQ42719872-DA45A687-CF85-4C8E-AA61-B59762701EA6Q48369070-FC9AC155-F65C-4F0D-B64A-4BE5B5A28689Q51577960-30EF7EF0-6964-427A-963E-10967B7FBF76Q53491178-336A229D-FB69-4B37-BE9C-F6F33A24CD6DQ58791672-4C88BCAE-3979-4AE7-9BCE-84A4A6BA9D84
P2860
TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor 1
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TNFSF15 inhibits vasculogenesi ...... le isoforms of VEGF receptor 1
@en
TNFSF15 inhibits vasculogenesi ...... e isoforms of VEGF receptor 1.
@nl
type
label
TNFSF15 inhibits vasculogenesi ...... le isoforms of VEGF receptor 1
@en
TNFSF15 inhibits vasculogenesi ...... e isoforms of VEGF receptor 1.
@nl
prefLabel
TNFSF15 inhibits vasculogenesi ...... le isoforms of VEGF receptor 1
@en
TNFSF15 inhibits vasculogenesi ...... e isoforms of VEGF receptor 1.
@nl
P2093
P2860
P356
P1476
TNFSF15 inhibits vasculogenesi ...... le isoforms of VEGF receptor 1
@en
P2093
Gui-Li Yang
Huai-Yuan Xiao
Jian-Wei Qi
Lu-Yuan Li
Ting-Ting Qin
Zhi-Song Zhang
P2860
P304
13863-13868
P356
10.1073/PNAS.1304529110
P407
P577
2013-08-05T00:00:00Z